Dvs Biolife Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-12-2024
- Paid Up Capital ₹ 0.50 M
as on 07-12-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.00 Cr
as on 07-12-2024
- Revenue -16.47%
(FY 2021)
- Profit -32.66%
(FY 2021)
- Ebitda -5.81%
(FY 2021)
- Net Worth 9.90%
(FY 2021)
- Total Assets 12.94%
(FY 2021)
About Dvs Biolife
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.00 Cr.
Iyengar Swamy, Gonuguntla Raghavan, Manjula Ramaiyengar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24129TG2004PLC043664
- Company No.
043664
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dvs Biolife?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gonuguntla Raghavan  | Director | 15-Jul-2004 | Current |
| Iyengar Swamy | Director | 05-Mar-2009 | Current |
| Venkatesh Devanur | Director | 22-Jun-2018 | Current |
| Manjula Ramaiyengar | Director | 15-Jul-2004 | Current |
| Gargeyee Devanur | Director | 01-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Dvs Biolife.
Dvs Biolife Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 16.47% decrease. The company also saw a substantial fall in profitability, with a 32.66% decrease in profit. The company's net worth moved up by a moderate rise of 9.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dvs Biolife?
In 2021, Dvs Biolife had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Som Phytopharma (India) LimitedActive 31 years 3 monthsIyengar Swamy, Manjula Ramaiyengar and 2 more are mutual person
- Agrilife (India) Private LimitedActive 2 years 3 months
Iyengar Swamy and Manjula Ramaiyengar are mutual person
- Koppert Sustainable Solutions (India) Private LimitedActive 29 years 7 months
Iyengar Swamy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 17 May 2017 | ₹5.00 Cr | Open |
How Many Employees Work at Dvs Biolife?
Unlock and access historical data on people associated with Dvs Biolife, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dvs Biolife, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dvs Biolife's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
